ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

British Journal of Dermatology

British Journal of Dermatology

Volume 102 Issue 4, Pages 443 - 445

Published Online: 29 Jul 2006

Journal compilation © 2010 British Association of Dermatologists



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: PDF (Size: 135K)  | Related Articles | Citation Tracking

A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea
E. M. SAIHAN* 1 J. L. BURTON 1
  1 Department of Dermatology, Bristol Royal Infirmary, Bristol
 

*The London Hospital, Whitechapel, London.

Copyright 1980 British Association of Dermatologists

ABSTRACT

AbstractREFERENCES

Forty patients with papulo-pustular rosacea were treated for 12 weeks on a random double-blind basis either with oxytetracycline 250 mg twice daily or with metronidazole 200 mg twice daily. Both drugs produced an improvement which was greater after 12 weeks than after 6 weeks, but there was no significant difference between them. Metronidazole appears to be a safe and effective drug for the treatment of rosacea.


Accepted for publication 17 July 1979

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1365-2133.1980.tb06558.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
Sign Up Now
Wiley Medical Twitter